XML 23 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows ( Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash flows from operating activities:    
Net income $ 19,995 $ 14,595
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 6,000 5,193
Amortization of other deferred charges 601 0
Amortization of deferred revenue (350) (280)
Amortization of deferred financing costs and debt discount 656 365
Accretion of asset retirement obligations 78 73
Deferred income taxes 0 25
Income from equity method investments (858) (245)
Dividends from equity method investments 1,033 0
Loss on asset disposals 60 12
Unit-based compensation expense 147 174
Changes in assets and liabilities:    
Accounts receivable (2,352) (4,610)
Inventories and other current assets 7,977 2,814
Accounts payable and other current liabilities 7,091 2,296
Accounts receivable/payable to related parties (15,790) 3,149
Non-current assets and liabilities, net (632) (87)
Net cash provided by operating activities 23,656 23,474
Cash flows from investing activities:    
Purchase of Big Spring logistics assets, net of assumed ARO liabilities (72,376) 0
Purchases of property, plant and equipment (3,253) (3,764)
Proceeds from sales of property, plant and equipment 91 0
Purchases of intangible assets (144,219) 0
Distributions from equity method investments 660 0
Equity method investment contributions 0 (1,650)
Net cash used in investing activities (219,097) (5,414)
Cash flows from financing activities:    
Proceeds from issuance of additional units to maintain 2% General Partner interest 13 0
Distributions to general partner (5,100) (3,994)
Distributions to common unitholders - public (6,590) (6,291)
Distributions to common unitholders - Delek (11,088) (10,252)
General Partner Distributions, Other 98,798 0
Proceeds from revolving credit facility 409,200 69,100
Payments of revolving credit facility (94,400) (69,700)
Reimbursement of capital expenditures by Delek 2,316 3,051
Net cash provided by (used in) financing activities 195,553 (18,086)
Net increase (decrease) in cash and cash equivalents 112 (26)
Cash and cash equivalents at the beginning of the period 4,675 59
Cash and cash equivalents at the end of the period 4,787 33
Cash paid during the period for:    
Interest 3,009 3,693
Non-cash investing activities:    
Non-Cash Investing Activities, Increase (Decrease) in Accrued Capital Expenditures (1,004) (973)
Non-cash financing activities:    
Sponsor contribution of fixed assets $ 0 $ 67